AGP Picks
View all

Furniture Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Furniture Press Releases.

Press releases published on November 2, 2026

STMicroelectronics announces status of common share repurchase program
CytomX Therapeutics to Present at Upcoming November Investor Conferences
New SEON Survey Finds U.S. Consumers Are Embracing AI Agents, but 65% Would Blame the AI Company if One Commits Fraud
Sionna Therapeutics to Participate in Upcoming November 2026 Investor Conferences
AssetMark Launches Private Wealth Program as New Research Highlights Growing High-net-worth Opportunity
Magna to Host Investor Day on November 11, 2026
Alfasigma Announces New Linerixibat Data Across PBC and Liver Disease to be Presented at AASLD’s The Liver Meeting 2026
Season’s Eatings: Tyson® Debuts New Holiday Nuggets
Rectitude Holdings Ltd. Announces Acquisition of MR. BUTLER PTE. LTD. and Executes Business Migration Agreements with INOS and G & L
Steric Systems Announces NMR Study Showing Changes in Beverage Molecular Interactions
Gold.com Appoints Nick Bowkett as Vice President of Trading and Business Development
Rein Therapeutics to Present at the Guggenheim 3rd Annual Healthcare Innovation Conference
Monopar to Present at AASLD – The Liver Meeting® 2026: Phase 3 FoCus Baseline Data and ALXN1840 Molybdenum Safety Data
Theriva™ Biologics Announces Sale of SYN-004 (ribaxamase) and Related Antibiotic-Degrading Enzyme Portfolio to Biossil Labs Inc.
Eyconis to Participate in Upcoming Investor Conferences
Cellectar Biosciences to Report Third Quarter Financial Results and Host a Conference Call on Tuesday, November 10, 2026
Humacyte To Announce 2026 Third Quarter Financial Results and Provide Business Update on November 10, 2026
New Data Presented at AHA Scientific Sessions 2026 Demonstrate That CARDAMYST® (etripamil) Nasal Spray Converted Recurrent PSVT to Normal Heart Rhythm in Patients with Prior Catheter Ablation
NeOnc Technologies to Present Data from Its NEO100 and NEO212 Programs at the 31st Annual Meeting of the Society for Neuro-Oncology
Theriva™ Biologics anuncia la venta de SYN-004 (ribaxamasa) y la cartera de enzimas degradadoras de antibióticos asociada a Biossil Labs Inc.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Furniture Press Releases

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.